Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siddhartha Mitra

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The Lancet. Oncology|October 16, 2022
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 studyZev A Wainberg, Peter C Enzinger, Yoon-Koo Kang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2019
Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic LeukemiaJeff P Sharman, Steven E Coutre, Richard R Furman, et al.
Scientific Reports|September 21, 2021
A Tunguska sized airburst destroyed Tall el-Hammam a Middle Bronze Age city in the Jordan Valley near the Dead SeaTed E Bunch, Malcolm A LeCompte, A Victor Adedeji, et al.
Nature Chemical Biology|November 1, 2011
Identifying polyglutamine protein species in situ that best predict neurodegenerationJason Miller, Montserrat Arrasate, Elizabeth Brooks, et al.
Nucleic Acids Research|November 26, 2011
GeneDB--an annotation database for pathogensFlora J Logan-Klumpler, Nishadi De Silva, Ulrike Boehme, et al.
Nature Medicine|June 30, 2014
Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibitionYujie Tang, Sharareh Gholamin, Simone Schubert, et al.
Journal for Immunotherapy of Cancer|January 13, 2023
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammationViktoria Marquardt, Johanna Theruvath, David Pauck, et al.
Oncogene|October 24, 2018
BMI1 is a therapeutic target in recurrent medulloblastomaDavid Bakhshinyan, Chitra Venugopal, Ashley A Adile, et al.
Nucleic Acids Research|October 22, 2009
TriTrypDB: a functional genomic resource for the TrypanosomatidaeMartin Aslett, Cristina Aurrecoechea, Matthew Berriman, et al.
Cell|February 24, 2018
A Hematogenous Route for Medulloblastoma Leptomeningeal MetastasesLivia Garzia, Noriyuki Kijima, A Sorana Morrissy, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Lancet. Oncology|October 16, 2022
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 studyZev A Wainberg, Peter C Enzinger, Yoon-Koo Kang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2019
Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic LeukemiaJeff P Sharman, Steven E Coutre, Richard R Furman, et al.
Scientific Reports|September 21, 2021
A Tunguska sized airburst destroyed Tall el-Hammam a Middle Bronze Age city in the Jordan Valley near the Dead SeaTed E Bunch, Malcolm A LeCompte, A Victor Adedeji, et al.
Nature Chemical Biology|November 1, 2011
Identifying polyglutamine protein species in situ that best predict neurodegenerationJason Miller, Montserrat Arrasate, Elizabeth Brooks, et al.
Nucleic Acids Research|November 26, 2011
GeneDB--an annotation database for pathogensFlora J Logan-Klumpler, Nishadi De Silva, Ulrike Boehme, et al.
Nature Medicine|June 30, 2014
Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibitionYujie Tang, Sharareh Gholamin, Simone Schubert, et al.
Journal for Immunotherapy of Cancer|January 13, 2023
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammationViktoria Marquardt, Johanna Theruvath, David Pauck, et al.
Oncogene|October 24, 2018
BMI1 is a therapeutic target in recurrent medulloblastomaDavid Bakhshinyan, Chitra Venugopal, Ashley A Adile, et al.
Nucleic Acids Research|October 22, 2009
TriTrypDB: a functional genomic resource for the TrypanosomatidaeMartin Aslett, Cristina Aurrecoechea, Matthew Berriman, et al.
Cell|February 24, 2018
A Hematogenous Route for Medulloblastoma Leptomeningeal MetastasesLivia Garzia, Noriyuki Kijima, A Sorana Morrissy, et al.
Pageof 5